Holy Family Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Liver cirrhosis2 trials
• Atrial fibrillation1 trial
• High blood pressure1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 2/31 trial

Status

• Active, not recruiting2 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• Galectin Therapeutics Inc.1 trial
• Janssen Research & Development, LLC1 trial
• Madrigal Pharmaceuticals, Inc.1 trial

Running trials

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

  NCT03900429· Phase 3· Madrigal Pharmaceuticals, Inc.· Source

Closed trials

• Terminated

  Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

  NCT04365868· Phase 2/3· Galectin Therapeutics Inc.· Source

• Completed

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· Phase 3· Eli Lilly and Company· Source